BR9914399A - Composto de piridopirazina, processo para sua produção e seu uso - Google Patents

Composto de piridopirazina, processo para sua produção e seu uso

Info

Publication number
BR9914399A
BR9914399A BR9914399-2A BR9914399A BR9914399A BR 9914399 A BR9914399 A BR 9914399A BR 9914399 A BR9914399 A BR 9914399A BR 9914399 A BR9914399 A BR 9914399A
Authority
BR
Brazil
Prior art keywords
production
compound
pyridopyrazine
pyridopyrazine compound
solvate
Prior art date
Application number
BR9914399-2A
Other languages
English (en)
Inventor
Norihiko Shimazaki
Masaru Watanabe
Masaharu Ichihara
Nobutaka Kawai
Koji Machiya
Kooji Kagara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9914399A publication Critical patent/BR9914399A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"COMPOSTO DE PIRIDOPIRAZINA, PROCESSO PARA SUA PRODUçãO E SEU USO". A invenção provê sal composto de piridopirazina novo da fórmula seguinte e seu cristal, que apresentam solubilidade e estabilidade muito satisfatórias. Mais particularmente, são providos o composto da fórmula acima, seu solvato e seus cristais.
BR9914399-2A 1998-09-29 1999-09-22 Composto de piridopirazina, processo para sua produção e seu uso BR9914399A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27444098 1998-09-29
PCT/JP1999/005182 WO2000018768A1 (fr) 1998-09-29 1999-09-22 Nouveaux sels d'un compose de pyridopyrazine et cristaux desdits sels

Publications (1)

Publication Number Publication Date
BR9914399A true BR9914399A (pt) 2002-01-22

Family

ID=17541719

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914399-2A BR9914399A (pt) 1998-09-29 1999-09-22 Composto de piridopirazina, processo para sua produção e seu uso

Country Status (13)

Country Link
EP (1) EP1118615A4 (pt)
KR (1) KR20010075287A (pt)
CN (1) CN1328555A (pt)
AU (1) AU5758199A (pt)
BR (1) BR9914399A (pt)
CA (1) CA2345362A1 (pt)
CZ (1) CZ20011164A3 (pt)
HK (1) HK1042896A1 (pt)
HU (1) HUP0103947A3 (pt)
IL (1) IL142147A0 (pt)
TR (2) TR200200971T2 (pt)
WO (1) WO2000018768A1 (pt)
ZA (1) ZA200102566B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1511516B1 (en) * 2002-05-28 2008-12-17 Nycomed GmbH Topically applicable pharmaceutical preparation
JP2006501269A (ja) * 2002-09-16 2006-01-12 アルコン マニュファクチャリング，リミティド 血管新生を処置するためのｐｄｅｉｖインヒビターの使用
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
CA2601250C (en) 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
KR20120073300A (ko) * 2009-09-30 2012-07-04 뗑따마르 에스아에스 휴대 가방 또는 조끼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008864A1 (en) * 1978-08-15 1980-03-19 FISONS plc Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them
AU594512B2 (en) * 1986-09-16 1990-03-08 Merck Patent Gesellschaft Mit Beschrankter Haftung Hydroxy indole derivatives
GB9413975D0 (en) * 1994-07-11 1994-08-31 Fujisawa Pharmaceutical Co New heterobicyclic derivatives

Also Published As

Publication number Publication date
CN1328555A (zh) 2001-12-26
WO2000018768A1 (fr) 2000-04-06
EP1118615A4 (en) 2002-02-27
ZA200102566B (en) 2002-07-18
CA2345362A1 (en) 2000-04-06
HUP0103947A3 (en) 2002-06-28
KR20010075287A (ko) 2001-08-09
HUP0103947A2 (hu) 2002-04-29
IL142147A0 (en) 2002-03-10
EP1118615A1 (en) 2001-07-25
HK1042896A1 (zh) 2002-08-30
AU5758199A (en) 2000-04-17
TR200100893T2 (tr) 2001-11-21
CZ20011164A3 (cs) 2001-12-12
TR200200971T2 (tr) 2002-06-21

Similar Documents

Publication Publication Date Title
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO930517L (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
DK0606046T3 (da) Arylsulfonamido-substituerede hydroxamsyrederivater
MX9302214A (es) Derivados de taxol y proceso para su preparacion
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
NO991494D0 (no) <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
FI934298A (fi) Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
NO922380L (no) Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling
BR9914399A (pt) Composto de piridopirazina, processo para sua produção e seu uso
NO954609D0 (no) Niopecotiske syrederivater som antitrombiske forbindelser
BR0011339A (pt) Composto, uso, e processo para preparar o mesmo, composição farmacêutica, e, método para tratar uma condição de doença mediada por metaloproteinase
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
DK0861250T3 (da) Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase
ATE214051T1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
DK0736009T3 (da) N-oxider af 4-arylpiperaziner og 4-arylpiperidiner som antipsykotiske medikamenter
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
DK486589D0 (da) Stabile oxapenem-3-carboxylsyrer og deres anvendelse som beta-lactamase-inhibitorer
ES2125474T3 (es) Derivados de piridazinona o sus sales, procedimentos para su produccion y agentes anti-shock que los contienen.
BR9815448A (pt) Derivados de imino-aza-antraciclinona para o tratamento de amiloidose

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.